Fistula News and Research

RSS
A Fistula is an abnormal opening or passage between two organs or between an organ and the surface of the body. Fistulas may be caused by injury, infection, or inflammation, or may be created during surgery.
First-of-its-kind nonsynthetic, decellularized graft one step closer to clinical trials

First-of-its-kind nonsynthetic, decellularized graft one step closer to clinical trials

Report: Overall burden of kidney disease remains high in the U.S.

Report: Overall burden of kidney disease remains high in the U.S.

FDA grants approval for new biosimilar to treat multiple types of cancer

FDA grants approval for new biosimilar to treat multiple types of cancer

MSC transplantation can be safe, effective approach to treat Crohn's disease-related fistula

MSC transplantation can be safe, effective approach to treat Crohn's disease-related fistula

Catheter use during hemodialysis linked to increased rates of bloodstream infections

Catheter use during hemodialysis linked to increased rates of bloodstream infections

Berlin meeting of colorectal specialists to drive best practice and innovation

Berlin meeting of colorectal specialists to drive best practice and innovation

FDA approves use of new Flourish device to treat infants born with esophageal atresia

FDA approves use of new Flourish device to treat infants born with esophageal atresia

Stivarga receives expanded FDA approval for treatment of liver cancer

Stivarga receives expanded FDA approval for treatment of liver cancer

Report reveals hospitalization, mortality rates for kidney disease patients continue to decrease in the U.S.

Report reveals hospitalization, mortality rates for kidney disease patients continue to decrease in the U.S.

Esperite's business unit develops therapy for Crohn's disease perianal fistulas

Esperite's business unit develops therapy for Crohn's disease perianal fistulas

New study questions longstanding belief related to hemodialysis patients treated with catheters

New study questions longstanding belief related to hemodialysis patients treated with catheters

Regenerative medicine shows promise for bronchopleural fistulas

Regenerative medicine shows promise for bronchopleural fistulas

FDA approves novel stomach-draining device to treat obesity

FDA approves novel stomach-draining device to treat obesity

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Excess activation of LOX may play causative role in progression of cardiac failure

Excess activation of LOX may play causative role in progression of cardiac failure

TVA Medical announces results from multicenter clinical study of everlinQ endoAVF System

TVA Medical announces results from multicenter clinical study of everlinQ endoAVF System

Nurse-trainer uses new approach to teach correct combination of HIV drugs to Angola's nurses

Nurse-trainer uses new approach to teach correct combination of HIV drugs to Angola's nurses

Symic receives $1.5M NIH Phase II SBIR grant to develop AVF therapeutic candidate

Symic receives $1.5M NIH Phase II SBIR grant to develop AVF therapeutic candidate

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Uninterrupted NOAC treatment during catheter ablation of atrial fibrillation is safe, shows research

Uninterrupted NOAC treatment during catheter ablation of atrial fibrillation is safe, shows research

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.